Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from crushresearch.shop, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
Lab "ILS Labs" reports purity within 0.41% std dev across 307 COAs
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| Adamax | 1 | 99.80% | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Thymosin Alpha-1 | CR-TAT10-0212-1 | Freedom Diagnostics | 99.51% | MSLAL | — | View |
| Ipamorelin/CJC-1295 | CR-CJIP10-2510-1 | Freedom Diagnostics | 99.83% | MSLAL | — | View |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| AOD-9604 | 2 | 99.43% | — | — | — |
| BPC-157 | 6 | 99.77% | — | — |
| BPC-157 + TB-500 | 4 | 99.84% | — | — | — |
| Cagrilintide | 1 | 99.69% | — | — | — |
| Epitalon | 3 | 98.77% | — | — |
| GHK-Cu | 7 | 99.68% | — | — |
| GLP-1 | 1 | 99.83% | — | — | — |
| Glutathione | 1 | 98.71% | — | — | — |
| Ipamorelin | 2 | 99.75% | — | — |
| Ipamorelin/CJC-1295 | 4 | 99.85% | — | — |
| Kisspeptin | 1 | 99.80% | — | — | — | — |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | 5 | 99.67% | — | — |
| KPV | 5 | 99.48% | — | — |
| Melanotan I | 2 | 99.68% | — | — | — |
| Melanotan II | 2 | 99.79% | — | — | — |
| MOTS-c | 6 | 99.73% | — | — | — |
| NAD+ | 5 | 98.97% | — | — | — |
| Pinealon | 1 | 99.70% | — | — | — | — |
| PT-141 | 1 | 99.93% | — | — | — |
| Selank | 2 | 99.78% | — | — | — |
| Semax | 2 | 99.72% | — | — | — |
| Sermorelin | 1 | 98.98% | — | — | — |
| TB-500 | 2 | 99.80% | — | — | — | — |
| Tesamorelin | 2 | 99.61% | — | — | — |
| Thymosin Alpha-1 | 1 | 99.51% | — | — | — |
| Tirzepatide | 8 | 99.74% | — | — |
| Triple Agonist | 23 | 99.80% | — | — |
| VIP (Vasoactive Intestinal Peptide) | 1 | 99.46% | — | — | — | — | — |
| Triple Agonist |
| CRRT-15-0312-1 |
| Freedom Diagnostics |
| 99.85% |
| MSLAL |
| — |
| View |
| GHK-Cu | CR-GHKC99-2511-1 | Freedom Diagnostics | 99.79% | MSLAL | — | View |
| GLP-RT | CRRT-15-1025-01 | Freedom Diagnostics | 99.97% | MSLAL | — | View |
| KPV | CR-KPV010-2601-1 | Freedom Diagnostics | 99.78% | MSLAL | — | View |
| Tirzepatide | CR-2XAG50-2607-White | ILS Labs | 99.78% | LALUSP<71>HM | 2026-07-10 | Stats only |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | CR-KLOW-80MG-2607-Black | ILS Labs | 99.51% | LALUSP<71>HM | 2026-07-10 | Stats only |
| Tirzepatide | CR-2XAG40-2607-Green | ILS Labs | 99.44% | LALUSP<71>HM | 2026-07-10 | Stats only |
| Retatrutide | CR-3XAG30-2606-Purple | ILS Labs | 99.79% | LALUSP<71>HM | 2026-07-02 | Stats only |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | CR-KLOW80-2606-YELLOW | ILS Labs | 99.95% | LALUSP<71>HM | 2026-07-02 | Stats only |
| BPC-157 | CR-BPC10-2606-BLUE | ILS Labs | 99.84% | LALUSP<71>HM | 2026-07-02 | Stats only |
| Adamax | CR-ADMX-10MG-2606-1 | ILS Labs | 99.80% | LALUSP<71>HM | 2026-07-02 | Stats only |
| MOTS-c | CR-MOTSC40-2606-BLUE | ILS Labs | 99.74% | LALUSP<71>HM | 2026-07-02 | Stats only |
| Tesamorelin | CR-TESA20-2606-GRAY | ILS Labs | 99.75% | LALUSP<71>HM | 2026-07-02 | Stats only |
| BPC-157 + TB-500 | CR-BPCTB20-2606-GREEN | ILS Labs | 99.84% | LALUSP<71>HM | 2026-07-02 | Stats only |
| Epitalon | CR-EPTH-10MG-2606-1 | ILS Labs | 97.87% | LALUSP<71>HM | 2026-06-27 | Stats only |
| NAD+ | CR-NAD-1000MG-2606-1 | ILS Labs | 97.91% | LALUSP<71>HM | 2026-06-26 | Stats only |
| BPC-157 | CR-BPC-5MG-2606-1 | ILS Labs | 99.87% | LALUSP<71>HM | 2026-06-26 | Stats only |
| Melanotan I | CR-MT1-10MG-2606-1 | ILS Labs | 99.46% | LALUSP<71>HM | 2026-06-26 | Stats only |
| GHK-Cu | CR-GHK-50MG-2606-1 | ILS Labs | 99.75% | LALUSP<71>HM | 2026-06-26 | Stats only |
| Retatrutide | CR-3XAG-30MG-2606-2 | ILS Labs | 99.65% | LALUSP<71>HM | 2026-06-26 | Stats only |
| Retatrutide | CR-3XAG-30-2606-1 | ILS Labs | 99.37% | LALUSP<71>HM | 2026-06-09 | Stats only |
| GHK-Cu | CR-GHKCU-100-2606-1 | ILS Labs | 99.57% | LALUSP<71>HM | 2026-06-09 | Stats only |
| KLOW Blend (GHK-Cu + BPC-157 + TB-500 + KPV) | CR-KLOW-80MG-2605-1 | ILS Labs | 99.65% | LALUSP<71>HM | 2026-06-05 | Stats only |
| GHK-Cu / KPV | CR2604GHKKP60-01 | ILS Labs | 99.19% | LALUSP<71>HM | 2026-06-05 | View |
| GHK-Cu / TB-500 / BPC-157 / KPV | CR-KLOW-80MG-2605-1 | ILS Labs | 99.65% | LALUSP<71>HM | 2026-06-05 | View |
| BPC-157 + TB-500 | CR-CRWOLF20-260602-01 | ILS Labs | 99.83% | LALUSP<71>HM | 2026-06-01 | Stats only |
| Glutathione | CRGLU-1500-2605-2 | ILS Labs | 98.71% | LALUSP<71>HM | 2026-06-01 | View |
| AOD-9604 | R-AOD-5-2605-1 | ILS Labs | 99.46% | LALUSP<71>HM | 2026-06-01 | View |
| MOTS-C | CRMTS-40-2605-1 | ILS Labs | 99.57% | LALUSP<71>HM | 2026-06-01 | View |
| MOTS-C | CRMTS-10-2605-1 | ILS Labs | 99.52% | LALUSP<71>HM | 2026-06-01 | View |
| MOTS-C | CR-MOTS20-2605-1 | ILS Labs | 99.73% | LALUSP<71>HM | 2026-06-01 | View |
| Selank | CR-SLK5-2605-1 | ILS Labs | 99.67% | LALUSP<71>HM | 2026-06-01 | View |
| CJC-1295 / Ipamorelin | CR-CJIP10-2605-1 | ILS Labs | 99.78% | LALUSP<71>HM | 2026-06-01 | View |
| Wolverine | CR-BPTB20-2605-1 | ILS Labs | 99.90% | LALUSP<71>HM | 2026-06-01 | View |
| Melanotan II | CR-MT2-10-2605-1 | ILS Labs | 99.78% | LALUSP<71>HM | 2026-06-01 | View |
| NAD+ | CR-NAD500-2605-1 | ILS Labs | 99.27% | LALUSP<71>HM | 2026-06-01 | View |
| MOTS-C | CRMTS-40-2605-2 | ILS Labs | 99.93% | LALUSP<71>HM | 2026-06-01 | View |
| Semax | CR-SMX-10-2605-1 | ILS Labs | 99.65% | LALUSP<71>HM | 2026-06-01 | View |
| NAD+ | CR-NAD-1000MG-2605-2 | ILS Labs | 99.22% | LALUSP<71>HM | 2026-06-01 | View |
| BPC-157 | CRBPC-10-2605-1 | ILS Labs | 99.86% | LALUSP<71>HM | 2026-06-01 | View |
| KPV | CR-KPV-10-2605-1 | ILS Labs | 99.19% | LALUSP<71>HM | 2026-06-01 | View |
| Triple Agonist | CR-3XAG20-2605-2 | ILS Labs | 99.94% | LALUSP<71>HM | 2026-06-01 | View |
| Sermorelin | CR-SMLN-10MG-2605-1 | ILS Labs | 98.98% | LALUSP<71>HM | 2026-06-01 | View |
| Double Agonist | CR-2XAG20-2605-1 | ILS Labs | 99.39% | LALUSP<71>HM | 2026-06-01 | View |
| Triple Agonist | CR26043XAG30-01 | ILS Labs | 99.90% | LALUSP<71>HM | 2026-05-27 | View |
| Triple Agonist | CR26043XAG50-01 | ILS Labs | 99.37% | LALUSP<71>HM | 2026-05-27 | View |
| Triple Agonist | CR26043XAG15-01 | ILS Labs | 99.81% | LALUSP<71>HM | 2026-05-27 | View |
| Triple Agonist | CR-3XAG10-2605-1 | ILS Labs | 99.79% | LALUSP<71>HM | 2026-05-20 | View |
Disclosed Labs